TABLE 3.

Representative 65-year-old American Society of Anesthesiologists III patient with a 3.1-cm unilocular side-branch traductal papillary mucinous neoplasm with 3 mm growth over the past year followed for 5 years using the Fukuoka, American College of Gastroenterology (ACG), and ChARM Post-treatment Reduced Radiographic Surveillance protocols

Unit	Unit cost, $	Total, $
Arm 1—following Fukuoka guidelines
6 EUS	2309.18	13,855.08
7 MRI	472.87	3310.09
Total imaging		17,165.17
7 clinic visits	174.79	1223.53
Total		18,388.70
Arm 2—following ACG guidelines
4 EUS	2309.18	9236.72
4 MRI	472.87	1891.48
Total imaging		11,128.20
4 clinic visits	174.79	699.16
Total		11,827.36
Arm 3—following ChARM protocol
1 EUS-FNI	2309.18	4618.36
4 MRI	472.87	1891.48
Total imaging		6509.84
4 clinic visits	174.79	699.16
Total		7209.00
Control arm—following Fukuoka guidelines for 2-3 cm
3 EUS-FNI	2309.18	6927.54
4 MRI	472.87	1891.48
Total imaging		8819.02
4 clinic visits	174.79	699.16
Total		9518.18

Control arm assumes a 2.5-cm cyst followed under the corresponding Fukuoka guidelines for a cyst of 2-3 cm.

EUS-FNI, Endoscopic ultrasound–guided fine-needle injection; MRI, magnetic resonance imaging.